ERJ Open Research · 2022 · 19 citations · 24 references
MedicineCardiologyInternal MedicineCardiac Nuclear MedicineDiagnostic ImagingDiagnostic RadiologyCardiac ImagingCardiac Sarcoidosis ImagingCardiothoracic ImagingCardiovascular ImagingElectrocardiography12-Lead Electrocardiography18F-fluorodeoxyglucose Positron Emission TomographyCardiac SarcoidosisEchocardiography ScreeningElectrocardiography ScreeningFluorine-18 Fluorodeoxyglucose Positron Emission TomographyIntracardiac EchocardiographyPositron Emission Tomography Detection
Background: Although screening with 12-lead electrocardiography and transthoracic echocardiography for cardiac involvement has been recommended for patients with biopsy-proven extracardiac sarcoidosis, cardiac sarcoidosis has been reported even in patients with normal electrocardiography and echocardiography findings. We investigated the prevalence and characteristics of these patient cohorts. Methods: F-fluorodeoxyglucose positron emission tomography and cardiac magnetic resonance imaging for cardiac sarcoidosis evaluation. The patients were categorised as those showing normal findings both in electrocardiography and transthoracic echocardiography (normal group) and those showing abnormal findings in one or both examinations (abnormal group). Results: 33 (29%) and 79 (71%) patients were categorised into the normal and abnormal groups, respectively, of which 6 (18%) and 43 (54%) patients, respectively, were diagnosed with cardiac sarcoidosis (p<0.01). Of these six patients in the normal group, two with multiple-organ sarcoidosis showed clinical deterioration of cardiac involvement and required steroid therapy; three with small cardiac involvement showed natural remission over follow-up assessments; and one underwent steroid therapy and showed an improvement in the left ventricular ejection fraction to within normal limits. Conclusions: The prevalence of cardiac sarcoidosis in patients with biopsy-proven extracardiac sarcoidosis and normal electrocardiography and transthoracic echocardiography findings was ∼20%. Electrocardiography and transthoracic echocardiography may not detect cardiac sarcoidosis in patients without conduction and morphological abnormalities. However, some of these patients may subsequently show clinically manifested cardiac sarcoidosis. Physicians should be mindful of this population.
24
Detection of Myocardial Damage in Patients With Sarcoidosis
Manesh R. Patel, Peter J. Cawley, John F. Heitner et al. · Circulation · 2009 · 717 citations · Full text
CLINICOPATHOLOGICAL STUDY ON FATAL MYOCARDIAL SARCOIDOSIS*
Yasuo Matsui, Kazuro Iwai, T Tachibana et al. · Annals of the New York Academy of Sciences · 1976 · 399 citations
Medicine, Cardiology, Pathology +15
Cardiac Involvement in Patients with Sarcoidosis
Davendra Mehta, Steven A. Lubitz, Zev Frankel et al. · CHEST Journal · 2008 · 396 citations